Tony Grover

Tony Grover is a seasoned executive in the medical device and diagnostics industry with over 20 years of expertise in commercial strategy, product launch, and reimbursement. He is currently the Global Director of Biomarkers and Companion Diagnostics (CDx) at BD, overseeing the companion diagnostics business. Previously, Tony was Chief Business Development Officer at Drawbridge Health, which was acquired by Thorne Health in 2021. He also served as VP of Business Development at Banyan Biomarkers, leading efforts on the first FDA-cleared blood test for concussions. Tony is the Chairman of the Biocom California Medical Device and Diagnostics Committee and a former Chairman of the Board for the American Heart Association, San Diego.